clinvestКачественная клиническая практикаKachestvennaya Klinicheskaya Praktika = Good Clinical Practice2588-05192618-8473ООО «Издательство ОКИclinvest-122Research ArticleФАРМАКОКИНЕТИКАPHARMACOKINETICSСравнительная оценка фармацевтического качества препаратов анастрозолаБелоусовЮ. Б.СоколовА. В.ЗыряновС. К.ЛелишенцевА. А.КамаевА. В.ЗверковЮ. Б.ГОУ ВПО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова», МоскваRussian FederationООО «Национальное агентство клинической фармакологии и фармации», г. МоскваRussian Federation201005062018011621Copyright © Белоусов Ю.Б., Соколов А.В., Зырянов С.К., Лелишенцев А.А., Камаев А.В., Зверков Ю.Б., 20182018Белоусов Ю.Б., Соколов А.В., Зырянов С.К., Лелишенцев А.А., Камаев А.В., Зверков Ю.Б.Белоусов Ю.Б., Соколов А.В., Зырянов С.К., Лелишенцев А.А., Камаев А.В., Зверков Ю.Б.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinvest.ru/jour/article/view/122фармэкспертизафармакохимическое исследованиекачество лекарстванастрозолгенерикифармацевтическая эквивалентностьReferences.Dixon J. M., Renshaw L., Bellamy C. et al. The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study//Clinical Cancer Research .- 2000 .- V . 6 .- P . 2229–2235.Dixon J. M., Renshaw L., Bellamy C. et al. The effects of neoadjuvant anastrozole (Arimidex) on tumor volume in postmenopausal women with breast cancer: a randomized, double-blind, single-center study//Clinical Cancer Research .- 2000 .- V . 6 .- P . 2229–2235.Tredway D. R., Buraglio M., Hemsey G. et al. A phase I study of the pharmacokinetics, pharmacodinamics, and safety of single- and multiple dose anastrozole in healthy, premenopausal female volunteers//Fertility and sterility .- .- V . 82, N .6 .- P . 1587–1592.Tredway D. R., Buraglio M., Hemsey G. et al. A phase I study of the pharmacokinetics, pharmacodinamics, and safety of single- and multiple dose anastrozole in healthy, premenopausal female volunteers//Fertility and sterility .- .- V . 82, N .6 .- P . 1587–1592.Arimidex Product monograph . AstraZeneca Canada inc . 2008; p .15.Arimidex Product monograph . AstraZeneca Canada inc . 2008; p .15.www .regmed .ru.www .regmed .ru.Newton P. N., Green M. D., Fernandez F. M., et al. Counterfeit antiinfective drugs . Lancet Infect Dis 2006; 6? 602–13.Newton P. N., Green M. D., Fernandez F. M., et al. Counterfeit antiinfective drugs . Lancet Infect Dis 2006; 6? 602–13.Boven K., Stryker S., Knight J., et al. The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes . Kidney Int 2005;67:2346–53.Boven K., Stryker S., Knight J., et al. The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes . Kidney Int 2005;67:2346–53.Limaye S., Steele R. H., Quin J., et al. An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity . J Allergy Clin Immunol 2002;110:530.Limaye S., Steele R. H., Quin J., et al. An allergic reaction to erythropoietin secondary to polysorbate hypersensitivity . J Allergy Clin Immunol 2002;110:530.Kowey P. R. Issues in bioequivalence and generic substitution for antiarrhythmic drugs (editorial) . Available from http://www .americanheart .org/presenter .jhtml?identifierј3015266 [Last accessed 18 Feb 2007].Kowey P. R. Issues in bioequivalence and generic substitution for antiarrhythmic drugs (editorial) . Available from http://www .americanheart .org/presenter .jhtml?identifierј3015266 [Last accessed 18 Feb 2007].Reiffel J. A. Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice . Am J Cardiol 2000;85:46–52.Reiffel J. A. Formulation substitution and other pharmacokinetic variability: underappreciated variables affecting antiarrhythmic efficacy and safety in clinical practice . Am J Cardiol 2000;85:46–52.Gross R. New findings in epilepsy from the 60 th Annual Meeting of the American Epilepsy Society: an expert interview . Medscape Neurol Neurosurg 2006;8 . Available from http://www .medscape .com/viewarticle/549148 [Last accessed 18 Feb 2007].Gross R. New findings in epilepsy from the 60 th Annual Meeting of the American Epilepsy Society: an expert interview . Medscape Neurol Neurosurg 2006;8 . Available from http://www .medscape .com/viewarticle/549148 [Last accessed 18 Feb 2007].Crawford P., Feely M., Guberman A., et al. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues . Seizure 2006;15:165–76.Crawford P., Feely M., Guberman A., et al. Are there potential problems with generic substitution of antiepileptic drugs? A review of issues . Seizure 2006;15:165–76
The authors declare that there are no conflicts of interest present.